Javascript must be enabled to continue!
Acute haemodynamic changes during haemodialysis do not exacerbate gut hyperpermeability
View through CrossRef
Abstract
Introduction: The gastrointestinal tract is a potential source of inflammation in dialysis patients. In vitro studies suggest breakdown of the gut barrier in uraemia leading to increased intestinal permeability and it is hypothesised that haemodialysis exacerbates this problem due to mesenteric ischaemia induced by blood volume changes during treatment.
Method: The effect of haemodialysis on intestinal permeability was studied in ten haemodialysis patients and compared with five controls. Intestinal permeability was assessed by measuring the differential absorption of four orally administered sugar probes which provides an index of small and whole bowel permeability. A multi-sugar solution (containing lactulose, rhamnose, sucralose and erythritol) was orally administered after an overnight fast. Plasma levels of all sugar probes were measured hourly for 10 h post-administration. In haemodialysis patients, the procedure was carried out twice — once on a non-dialysis day and once immediately after haemodialysis.
Results: Area under curve (AUC) for lactulose:rhamnose (L:R) ratio and sucralose:erythritol (S:E) ratio was similar post-dialysis and on non-dialysis days. AUC for L:R was higher in haemodialysis patients compared with controls (0.071 vs. 0.034, P=0.001), AUC for S:E ratio was not significantly different. Levels of lactulose, sucralose and erythritol were elevated and retained longer in haemodialysis patients compared with controls due to dependence of sugars on kidney function for clearance.
Conclusion: We found no significant acute changes in intestinal permeability in relation to the haemodialysis procedure. Valid comparison of intestinal permeability between controls and haemodialysis patients was not possible due to the strong influence of kidney function on sugar levels.
Title: Acute haemodynamic changes during haemodialysis do not exacerbate gut hyperpermeability
Description:
Abstract
Introduction: The gastrointestinal tract is a potential source of inflammation in dialysis patients.
In vitro studies suggest breakdown of the gut barrier in uraemia leading to increased intestinal permeability and it is hypothesised that haemodialysis exacerbates this problem due to mesenteric ischaemia induced by blood volume changes during treatment.
Method: The effect of haemodialysis on intestinal permeability was studied in ten haemodialysis patients and compared with five controls.
Intestinal permeability was assessed by measuring the differential absorption of four orally administered sugar probes which provides an index of small and whole bowel permeability.
A multi-sugar solution (containing lactulose, rhamnose, sucralose and erythritol) was orally administered after an overnight fast.
Plasma levels of all sugar probes were measured hourly for 10 h post-administration.
In haemodialysis patients, the procedure was carried out twice — once on a non-dialysis day and once immediately after haemodialysis.
Results: Area under curve (AUC) for lactulose:rhamnose (L:R) ratio and sucralose:erythritol (S:E) ratio was similar post-dialysis and on non-dialysis days.
AUC for L:R was higher in haemodialysis patients compared with controls (0.
071 vs.
0.
034, P=0.
001), AUC for S:E ratio was not significantly different.
Levels of lactulose, sucralose and erythritol were elevated and retained longer in haemodialysis patients compared with controls due to dependence of sugars on kidney function for clearance.
Conclusion: We found no significant acute changes in intestinal permeability in relation to the haemodialysis procedure.
Valid comparison of intestinal permeability between controls and haemodialysis patients was not possible due to the strong influence of kidney function on sugar levels.
Related Results
MO916THE EFFECT OF EXTENDED HAEMODIALYSIS ON NUTRITIONAL PARAMETERS: A SYSTEMATIC REVIEW
MO916THE EFFECT OF EXTENDED HAEMODIALYSIS ON NUTRITIONAL PARAMETERS: A SYSTEMATIC REVIEW
Abstract
Background and Aims
Individuals who receive haemodialysis have a high mortality rate, up to 20% within one year of star...
Intracellular signalling involved in modulating human endothelial barrier function*
Intracellular signalling involved in modulating human endothelial barrier function*
AbstractThe endothelium dynamically regulates the extravasation of hormones, macromolecules and other solutes. In pathological conditions, endothelial hyperpermeability can be indu...
Explaining Indonesian Patients’ Experiences About Changes in the Hemodialysis Cost System
Explaining Indonesian Patients’ Experiences About Changes in the Hemodialysis Cost System
Aim: To explore the experience of haemodialysis patients in Indonesia over a decade, amidst changes in the cost system in hospitals. Since its implementation, the Universal Health ...
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort
ABSTRACTBackgroundLymphocyte ratios reflect inflammation and have been associated with adverse outcomes in a range of diseases. We sought to determine any association between neutr...
Guest Editorial – Pulmonary Embolism: the risk of what we don’t yet know!
Guest Editorial – Pulmonary Embolism: the risk of what we don’t yet know!
Pulmonary embolism (PE) is a common and potentially life-threatening condition encountered routinely in acute care.1, 2 The diagnosis and management of PE has been the topic of Nat...
THE ANTICOAGULANT THERAPY OF HAEMODIALYSIS PATIENTS WITH ACUTE CORONARY SYNDROME
THE ANTICOAGULANT THERAPY OF HAEMODIALYSIS PATIENTS WITH ACUTE CORONARY SYNDROME
Objectives
To evaluate the effect of different dose of anticoagulants in haemodialysis patients with acute coronary syndrome (not including ST-elevate myocardial ...
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
Abstract
BACKGROUND AND AIMS
Patients with chronic kidney disease (CKD) stage 5 on haemodialysis are at a high risk of cardiovas...
Barriers to Infection Prevention Adherence and Compliance in Haemodialysis Units in South Africa: A Qualitative Study
Barriers to Infection Prevention Adherence and Compliance in Haemodialysis Units in South Africa: A Qualitative Study
Abstract
Introduction: The burden of infections in haemodialysis environments remains worldwide. Owing to the multiple activities within haemodialysis environments,...

